Pentapeptide commonality betweenCorynebacterium diphtheriaetoxin and theHomo sapiensproteome

The oligodeoxynucleotide sequences corresponding to never-expressed peptide motifs are mainly located in the non-coding strand

(2010) Giovanni Capone et al.   BMC BIOINFORMATICS

Protein information content resides in rare peptide segments

(2010) Darja Kanduc   PEPTIDES

Sensitivity of Cancer Cells to Truncated Diphtheria Toxin

(2010) Yi Zhang et al.   PLoS One

Surveillance for adverse events after DTwP/Hib vaccination in Brazil: Sensitivity and factors associated with reporting

(2010) Sandra Aparecida Moreira Gomes Monteiro et al.   VACCINE

Overview of the development and current use of CRM197 conjugate vaccines for pediatric use

(2010) Henry R. Shinefield   VACCINE

Les réactions d’hypersensibilité allergique et non allergique aux vaccins contenant des anatoxines

(2009) C. Ponvert   ARCHIVES DE PEDIATRIE

Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study

(2009) Lisa A Jackson et al.   BMC INFECTIOUS DISEASES

Adverse Events After Administration of Tetanus-Diphtheria-Acellular Pertussis Vaccine to Healthcare Workers

(2009) Thomas J. Sandora et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Infections and autoimmunity: the multifaceted relationship

(2009) P. Sfriso et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The Immune Epitope Database 2.0

(2009) Randi Vita et al.   NUCLEIC ACIDS RESEARCH

Cellular Immunity as a Potential Cause of Local Reactions to Booster Vaccination With Diphtheria and Tetanus Toxoids and Acellular Pertussis Antigens

(2009) David W. Scheifele et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Codon number shapes peptide redundancy in the universal proteome composition

(2009) Anthony Kusalik et al.   PEPTIDES

Immune Modulation by Adjuvants Combined with Diphtheria Toxoid Administered Topically in BALB/c Mice After Microneedle Array Pretreatment

(2009) Z. Ding et al.   PHARMACEUTICAL RESEARCH

Safety experience with heptavalent pneumococcal CRM197-conjugate vaccine (Prevenar®) since vaccine introduction

(2009) Kimberly J. Center et al.   VACCINE

HER-2/neu (657-665) represents an immunogenic epitope of HER-2/neu oncoprotein with potent antitumor properties

(2009) Angelos D. Gritzapis et al.   VACCINE

Surveillance of Vaccine Safety: Comparison of parental reports with routine surveillance and a clinical trial

(2009) Eva Netterlid et al.   VACCINE

Antigen processing of glycoconjugate vaccines; the polysaccharide portion of the pneumococcal CRM197 conjugate vaccine co-localizes with MHC II on the antigen processing cell surface

(2009) Zengzu Lai et al.   VACCINE

Immunogenicity and safety of diphtheria–tetanus vaccine in pre-adolescent and adolescent South Koreans

(2009) Soo Young Lee et al.   VACCINE

An assessment of the safety of adolescent and adult tetanus–diphtheria–acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink

(2009) W. Katherine Yih et al.   VACCINE

Antibodies to citrullinated α-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase

(2008) Karin Lundberg et al.   ARTHRITIS AND RHEUMATISM

Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects

(2008) Darja Kanduc   EXPERT OPINION ON BIOLOGICAL THERAPY

Primary biliary cirrhosis following lactobacillus vaccination for recurrent vaginitis

(2008) Dimitrios Bogdanos et al.   JOURNAL OF HEPATOLOGY

Recurrence of Cardiorespiratory Events following Repeat DTaP-Based Combined Immunization in Very Low Birth Weight Premature Infants

(2008) Aline Flatz-Jequier et al.   JOURNAL OF PEDIATRICS

Extensive Antibody Cross-reactivity among Infectious Gram-negative Bacteria Revealed by Proteome Microarray Analysis

(2008) Sarah L. Keasey et al.   MOLECULAR & CELLULAR PROTEOMICS

Massive peptide sharing between viral and human proteomes

(2008) Darja Kanduc et al.   PEPTIDES

A clinical trial examining the effect of increased total CRM197 carrier protein dose on the antibody response to Haemophilus influenzae type b CRM197 conjugate vaccine

(2008) Vytautas Usonis et al.   VACCINE